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Experimental allergic encephalomyelitis (EAE)' is produced by injecting whole
central nervous system tissue or the myelin basic protein (BP), emulsified in
complete Freund's adjuvant (CFA), into genetically susceptible animals. In rats,
the major encephalitogenic determinant of BP is contained in a 43 amino acid
fragment, residues 45-87 (Fig. 1), ofthe myelin basic protein (1). Recently, it has
been demonstrated that the capacity to develop EAE in rats is under control ofa
gene, designated by Williams and Moore (2) as the Ir-EAE gene, which is linked
to the major histocompatibility locus in the rat (2, 3). However, the mechanisms
responsible for genetic control are unknown. In the present study both cell-
mediated immunity and antibody formation to the intact myelin basic protein
and to the 43 residue encephalitogenic fragment (EF) were investigated in the
highly susceptible Lewis (Le) rats, which are homozygous for the Ir-EAE gene,
and in the resistant Brown Norway (BN) rats which lack the Ir-EAE gene. The
findings indicate that only Le rats have the capacity to mount a cell-mediated
immune response against the EF, but that both strains of rats have the capacity
to develop antibody against other portions of the BP molecule. Antibody
production is greater in the Le rat suggesting that the encephalitogenic
determinant, recognized by T cells of the Le rat, may function as a helper
determinant in the production of antibody.
* Work supported by Research Grants 761-A and 464-E from the National Multiple Sclerosis
Society andGrant NS 10721 and NS-11418 from the National Institute for Neurological Diseases and
Stroke.
tRecipient of Career Research Award NS 50266.
'Abbreviations used in this paper: ABC, molar-binding antigen capacity; BN, Brown Norway;
BP, basic protein; EF, encephalitogenic fragment; EAE, experimental allergic encephalomyelitis;
GPBP, guinea pig basic protein; IFA, incomplete Freund's adjuvant; Le, Lewis; LNC, lymph node
cells; MIF, migration inhibitory factor; PEC, peritoneal exudate cells; RIEP, radioimmunoelectro-
phoresis.
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Phe-Gly-Ser-Asp-Arg-Ala-Ala-Pro-Lys-Arg-Gly-Ser-Gly-Lys-Asp-
Ser-His-His-Ala-Ala-Arg-Thr-Thr-His-Tyr-Gly-Ser-Leu-Pro-Gln-
87
Lys-Ser-Gln-Arg-Ser-Gln-Asp-Gly-Asn-Pro-Val-Val-His-CooH
FIG. 1 .
￿
Sequence of guinea pig fragment which contains themain encephalitogenic determi-
nant for the rat. The complete sequence of GPBP is unknown and the residue numbering
system is based on thesequence for the bovine BP.
Materials and Methods
Experimental Design. Female Le and BN rats were challenged with guinea pig basic protein
(GPBP) . Beginning on day 7 after challenge, they were examined daily for signs of EAE. In early
experiments groups of 10 rats were injected. Two rats were sacrificed at various intervals after
challenge. Sera were studied for the capacity to bind radioiodinated GPBP, and lymph node cells
(LNC) were tested for the capacity to undergo lymphocyte stimulation and to produce migration
inhibitory factor (MIF). After establishing the optimal times to study the above parameters, groups of
five rats of each type were compared at preselected times.
Animals.
￿
Female BN andLe rats were obtained from Microbiological Associates, Inc. (Bethesda,
Md.) housed five to a cage andfed Purina RatChow (Ralston Purina Co., St. Louis, Mo.) and water ad
lib. They were challenged between 4 and 6 mo of age.
Preparation of GPBP and EF.
￿
BP was prepared from guinea pig brains (Pal-Freez Bio-Animals,
Inc., Rogers, Ark.) by the standard procedure of this laboratory (1) ; an acid extract of the chloroform-
methanol defatted brains was chromatographed on carboxymethyl cellulose using a linear salt gradi-
entin glycine buffer, 2M urea, pH 10.4. The last peak eluted from the column, the major peak of BP,
was desalted and lyophilized. The fragment containing the major encephalitogenic site was pre-
pared by previously described methods (4).
Injection Procedure. In order to study the primary immune response, BP was dissolved in
Ringer's solution and added to an equal volume of CFA (Difco Laboratories, Detroit, Mich.)
containing freshly ground Mycobacterium butyricum. Each rat received a total of 0.1 ml of the
emulsion equally divided between the hind foot pads; i.e., 50 gg ofGPBP and250 mg of mycobacteria.
To study the secondary immune response rats were boosted intraperitoneally with 250 ug BP
emulsified in 1 ml of incomplete Freund's adjuvant (IFA). In order to have a reference anti-BP
antiserum for a positive control in radioimmunoassay, rats were hyperimmunized by the intraperito-
neal injection of 250 kg BP in IFA every 3-4 wk. After the fourth boost, the animals were exsan-
guinated and the serum stored in 0.2-ml aliquots at -20°C.
Iodination of Basic Protein.
￿
A modification of the lactoperoxidase method (5) was employed. 10
mCi ["'I]Na (New England Nuclear, Boston, Mass.), obtained in the smallest possible vol of 0.1 N
NaOH in a V-shaped vial, was neutralized with 0.5 M NaH,PO, containing 5 x 10-° molKI. BP was
dissolved at a concentration of 1 .0 mg/ml in 0.15 M NaCl at pH 7.3 with 0.05 M phosphate buffer. 10
pl of BP solution was added to the neutralized [111I]Na followed by 10 jul of 0.1% lactoperoxidase
(Sigma lot no. 14C-0690, Sigma Chemical Co., St. Louis, Mo.), and 10 Al 0.03% H,O,. After 10 minthe
reaction was stopped by the addition of 500gl of5 x 10- 'M cysteine HCI. Excess iodine wasremoved
by filtration through a Sephadex G-10 column equilibrated with 0.01 N HCl containing 0.1% bovine
serum albumin; 0.25 ml fractions were collected and counted in an autogamma counter. The
radioactive peak collected at the void volume was 90-100% precipitable with 10%trichloroacetic acid,
andreacted in radioimmunoassay with the standard anti-BP . Only radioiodinated BP which fulfilled
these criteria was used in radioimmunoassay described below. This procedure results in the
substitution of 1-2 mol "6I per mole of BP assuming complete recovery of the BP. For
radioimmunoelectrophoresis (RIEP) BP was iodinated with "'I in the same manner.
Preparation of Rabbit Antisera to RatImmunoglobulins
IgG.
￿
Le rat serum was added to an equal volume of saturated ammonium sulfate. The resulting
precipitate was suspended and dialyzed against 0.02 M Tris HCl at pH 8.2 and conductivity 0.7
mmho and applied to aDEAE column (DE52, H. Reeve Angel &Co., Inc., Clifton, N.J.) equilibrated74
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with the same buffer. The breakthrough fractions were pooled and concentrated. The column was
then eluted with starting buffer to which sufficient NaCl had been added to increase theconductivity
to 2.0 mmho . The fractions were pooled and concentrated. Both pools were analyzed by immunoelec-
trophoresis using rabbit anti-whole rat serum (Microbiological Associates) . Preparations which
showed only IgG were used for immunization of adult NewZealand white rabbits. 2 mg of the rat IgG
was emulsified in CFAand injected intradermally at multiple sites along the back. 4 wk later rabbits
were boosted intravenously with alum precipitated IgG for 5 successive days for a total of 10 mg (6) .
7-10 days following the last boost, the animals were bled .
IgM.
￿
An euglobulin precipitate was prepared by dialysis of 40 ml of rat serum against multiple
changes of 1% boric acid for 72 h. The precipitate was washed in 1% boric acid, suspended in and
dialyzed against borate-buffered saline (BBS), andfiltered through Sephadex G 200; protein eluting
the void volumn was pooled and concentrated. Rabbits were injected intradermally with 1 mg
emulsified in CFA, and boosted 1 mo later with 1 mg in IFA. 10 days after the last injection, the
rabbits were bled. When tested in immunoelectrophoresis the rabbit antiserum showed antibodies
against IgM, IgG, and three proteins in the alpha and beta globulin region. Antibodies against IgG
were removed by absorption with IgG. The resulting antiserum (no . 4171) was used in RIEP.
Detection of Anti-BPAntibodies
RIEP.
￿
Rat sera were subjected to immunoelectrophoresis using onewell and two troughs. The rat
serum was mixed with an equal vol of ["'I]BP (1 x 10- ' M) and added to the central well. After
electrophoresis one trough was filled with rabbit antirat IgG, and the other trough with rabbit
antiserum no. 4171. After developing, the slides were photographed, washed in BBS for 48 h, washed
in water for 1 h, dried and allowed to develop on Kodak X-ray film (Eastman Kodak Co., Rochester,
N.Y.) for optimal periods of time.
QUANTITATIVE BINDING. Reactivity of radioiodinated BP with serum from immunized rats was
sought by Farr's method (7) using 50% saturated ammonium sulfate to precipitate antigen-antibody
complexes. Although increased binding was found by immune rat sera, the binding ofnormal rat sera
was 20-25%, which is higher than with other antigens. RIEP analysis of normal rat serum with
[111I]BP showed binding to two alpha globulins which was presumably responsible for the increased
background (6) . RIEP analysis of sera from rats hyperimmunized with GPBP also showed binding to
the two alpha globulins as well as binding to IgG. Therefore, a radioimmunoassay was developed
using the rabbit antirat IgG described above to precipitate the antigen-antibody complexes.
10 pl of rat serum were added to disposable Falcon plastic tubes (no. 2052, Falcon Plastics, Div. of
BioQuest, Oxnard, Calif.) followed by 100 dal of 0.2 M borate buffer containing 0.05% normal rat
serum, 10-8 M GPBP and an amount of ["'I]BP sufficient to give approximately 108 cpm. The
samples were incubated at 37°C for 1 h; 100,ul of specific rabbit antirat IgG serum containing 3 mg
antibody/ml were added and incubation continued at 37°C for 30 min and then at 4°C for 2h. The
tubes were centrifuged at 1,750 g at 4°C for 90 min, the supernates aspirated, and precipitates
counted. In each determination controls included assay of normal rat serum and the standard rat
anti-BP antiserum . The percent binding and the molar binding antigen capacity (ABC) were
calculated by the method of Brownstone et al. (9). In the results reported below, the percentage of
binding by the standard rat anti-BP serum was reproducible within 5% or less from experiment to
experiment.
Studies of Cell-Mediated Immunity
SKIN TEST.
￿
Skin tests were performed on a shaved area of the abdomen. Preliminary studies, as
reported by others (2, 10), revealed that skin tests diminish and may even become negative as EAE
develops . Therefore, animals were studied on the 9th day after immunization . Groups of five rats of
each type were injected intradermally with either 50,ug GPBP or an equimolar amount ofEF (12.5,ug)
dissolved in 0 .1 ml of saline. The diameter of the erythema and induration was measured at 1, 4, 24,
and 48 h after injection. In some experiments the area of induration was excised at 48 h, fixed in 10%
formalin, sectioned, and stained with hematoxylin and eosin.
PREPARATION OF LYMPH NODE CELL SUSPENSION.
￿
At various intervals after immunization, rats were
killed by cervical dislocation and the draining lymph nodes were removed, dissected from the
surrounding connective tissue, and teased in cold PBS. The suspension of LNC was filtered tnrough
sterile gauze, washed in sterile PBS, counted and the viability determined by 1% trypan blue
exclusion.MCFARLIN, HSU, SLEMENDA, CHOU, AND KIBLER
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LYMPHOCYTE STIMULATION .
￿
LNC were resuspended in medium 199containing 20%fresh, syngeneic
rat serum at a concentration of 2 x 10' cells per ml and the appropriate concentration of antigen or
mitogen. In preliminary studies, 50 gg of basic protein, 12.5 leg of EF and 2.5 kg of phytohemag-
glutinin (MR 68, Wellcome Research Laboratories, Beckenham, England) per ml gave the
maximum responses, respectively. LNC from each animal were cultured in the absence of antigen
andat the above concentrations ofBP, EF, and PHA. A microculture system usingplastic microtiter
(Falcon no. 3040) was employed; 0.2 ml of the cell suspension was addedto each well. Quadriplicate
cultures were established foreach variable. The microtiter plates containing thelymphocyte cultures
were incubated at 37°C in 5% CO, and harvested after 24, 48, and 72 h. 4 h before harvest, 10,ul of
medium 199 containing 20,uCi/ml of NET-027 (methyl-'Hlthymidine (spec act 6.7 Ci/mmol, New
England Nuclear) were added to each well. The cultures were harvested using an automatic cell
harvester (MashII apparatus, Microbiological Associates) . Cells were collected on filters which were
driedand added to scintillation counting vials containing 12 ml of Nuclear-Chicago counting solution
(Nuclear Chicago Corp., Des Plaines, Ill.) and counted in a Packard liquid scintillation counter
(Packard Instrument Co., Downers Grove, Pa.) . A stimulation index was calculated by dividing the
mean cpm of stimulated cultures by the mean cpm of unstimulated cultures. An index of 1.5 or
greater was regarded as significant. In individual experiments the mean responses and standard
deviation forgroups of five rats of each type were calculated andcompared usingaStudent's ttest.
MACROPHAGE MIGRATION. Peritoneal exudate cells (PEC) were obtained by injecting male
syngeneic rats with 10 ml of sterilized paraffin oil. 5 days later the rats were exsanguinated; the
peritoneal cavities were opened aseptically and lavaged with sterile PBS containing 10 U of heparin
(Pan Heparin, Abbott) per ml. The PEC were washed three times in PBS and adjusted to a
concentration of 2 x 10' cells/ml. To this suspension was added an equal vol of 2 x 10' LNC/ml
obtained from the draining nodes ofindividual rats. Aliquots ofPEC andLNC were incubatedboth in
the absence and the presence of antigen. The same concentrations of antigen used in lymphocyte
transformation were employed. The macrophage migration was performed by radial diffusion in
agarose by a modification of the method developed by Gaines et al. (11) . Plastic tissue culture dishes
(Falcon no . 3002) containing 0.67% agarose in medium 199 supplemented with 10% fresh syngeneic
rat serum was prepared immediately before use. Wells were cut in the agarose, filled with the cell
mixtures and incubated at 37°C for 24 h in 5% CO,. The preparations were then fixed in 10% acetic
acid, stained with Ponceau S andtheagarose removed. The surface was allowed to dry, the patterns
projected on graph paper andtheareas of cell migration measured . Amigration inhibition indexwas
calculated by dividing thearea of migration of cells incubated in the presence of antigen by the area
of migration of cells incubated in theabsence of antigen, multiplied by 100. An index below80% was
felt to representsignificant inhibition. In afewstudies, indirect macrophage migration wasperformed
by adding supernates from LNC, cultured either in thepresence or in theabsenceof antigen, to PEC
prepared as described above.
Results
Skin Test.
￿
The skin test results 9 days after original challenge are shown in
Table I. Immediate skin reactions did not occur. Both BN and Le produced
positive delayed reactions when challenged with GPBP. The enduration was
maximal between 24 and 48 h. Microscopically, the site had the typical
appearance of a dalayed skin reaction with infiltration of mononuclear cells. In
Le rats, the reactions were more intense, both grossly and microscopically. Le
rats also developed definite delayed reactions to the EF; however, the magnitude
of the reactions against EF was always less than that seen against the intact
GPBP. BN rats showed neither gross nor histological evidence of a delayed skin
reaction to the EF. In other experiments in which BN and Le rats were skin
tested with either GPBP or EF 4 wk after initial challenge, the findings were
essentially the same.
Lymphocyte Stimulation.
￿
In pilot studies Le and BN rats were sacrificed at76
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TABLE I
Results of Skin Testing
Groups of BN and Le rats challenged with 501+g GPBP were skin tested with either GPBP or EF 9
days after challenge. There wasno reaction in the first 4h; theresults after 48 h are shown. All skin
test sites were biopsied and studied microscopically.
* Diameter of enduration in mm at 48 h.
$ Negative both grossly and microscopically .
various intervals after challenge and cells from the draining lymph nodes were
tested for their capacity to undergo in vitro stimulation when cultured with either
GPBP or EF. LNC from both BN and Le rats immunized with CFA alone did not
exhibit any significant lymphocyte stimulation to BP. In Le rats challenge with
BP, the maximal response (SI) was observed at 11-12 days after challenge, which
coincided with the onset of clinical symptoms . The response in BN rats
challenged with BP, although considerably less than that seen in Le rats, was
also maximal at 11-12 days. In subsequent experiments, groups of five Le and five
BN rats were sacrificed at day 11 and the in vitro response of the LNC from each
rat measured. The results of one experiment are shown in Table II. LNC from Le
rats showed a definite incorporation of [9H ]thymidine when exposed to the intact
BP; furthermore, the mean response to the 43 residue EF was indistinguishable
from that of the intact protein . In contrast BN rats showed only marginal
response to the BP (SI 2 .0 t 0 .7) and no significant response to the EF.
Macrophage Migration.
￿
The capacity of LNC from five Le and five BN rats
to inhibit the migration of PEC was also assessed 11 days after challenge. The
results are shown in Table II. Le LNC produced significant inhibition of PEC
migration when incubated with either the intact BP or with the EF. In contrast,
BN LNC did not produce significant MIF to either of these proteins. In order to
determine if a soluble factor was responsible for the macrophage migration
inhibition an indirect MIF assay was employed. Supernates from Le LNC
cultures incubated either with or without BP for 48 h were added to the PEC
preparation and assayed for MIF. There was significantly less migration with the
supernate obtained from LNC incubated with BP, indicating that a soluble
factor was responsible for the inhibition of migration.
Antibody Formation.
￿
After challenge with 50 lug of GPBP rats were exsan-
guinated by cardiac puncture at various intervals ; the sera were tested for
anti-BP protein antibody by radioimmunoassay (Fig. 2). In the Le rats
significant binding (ABC above 1 .0) was not detected until day 21, and a peak
mean ABC of 4 .2 was observed at day 32 . In contrast, sera from BN rats did not
show significant binding. After boosting with 250 jug GPBP on day 34, the ABC
Le rats BN rats
Antigen
No. positive/ Mean* No. positive/ Mean
no. tested induration no. tested induration
mm mm
GPBP 5/5 5.8 4/4 3.0
EF 5/5 3.2 0/5$ -m i
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TABLE 11
In Vitro Lymphocyte Responses
Lymph node cells from 5 BN and 5 Le rats challenged with 50 Ag GPBP were tested for their capacity
to undergo lymphocyte transformation and to inhibit the migration of PEC. The mean responses to
GPBP and EF are shown.
DAY AFTER CHALLENGE
FIG. 2.
￿
The mean anti-BP antibody responses in BN andLe rats challenged with 50 pig GPBP
on day0and boosted with 250Ag GPBP on day 35 . Each point is the mean response of groups of
three to five animals.
rose to 8.1 in Le and to 2.2 in BN rats. In a subsequent experiment (Table III) Le
and BN rats were bled via thetail vein 32 days after challenge, boosted on day 34,
and rebled on day 48. At the time of the first bleeding Le serum showed a mean
ABC of4.1 while the mean ABC of BN sera was insignificant. After the second
Le BN P
Lymphocyte transformation
(stimulation index)
BP 6.412.8 2.010.7 <0.01
EF 6.512.5 1.210.3 <0.01
PHA 22.6 11 .9 17.7f3.3 NS
Macrophage migration (%)
BP 64. t 5.0 95. t 2.0 0.001
EF 66. f 5.0 98. t 2 .0 0.00178
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TABLE III
Antibody Formation in Rats-Antigen-Binding Capacity X10-8 M
Groups of Le and BN rats were challenged with 50 l+g GPBP and the
primary antibody response measured on day 32. The rats were boosted
with 250 gg on day 35 and the secondary antibody response measured on
day 48. The mean response t one standard deviation for groups of five
rats are shown.
* After challenge with 50 Fig GPBP in FCA.
$ Secondary response following boost with 250pg in ICA day 35.
injection on day 34 there was a rise in ABC in both strains; to 7 .6 in Le rats and
1 .8 in BN rats.
Sera were also studied by RIEP using [ 131I]BP. In all Le sera with significant
ABC there was reactivity between the BP and IgG and in an occasional serum
there was also reactivity with IgM . In addition, it is noteworthy that sera from
some BN rats obtained 21 and 28 days after challenge showed faint binding with
IgG, indicating that BN rats produce small amounts of anti-BP antibody
undetectable by the radioimmunoassay. However, no serum obtained before
day 21 from rats of either strain showed binding of antigen by RIEP . All sera from
boosted animals of both strains showed reactivity with IgG and in an occasional
serum from both BN and Le rats there was also binding to IgM .
Antibody Binding Site .
￿
Because the in vitro studies of cell-mediated immu-
nity described above indicated the reaction to EF was equal to that of the entire
BP molecule, it seemed important to determine if the antibody was directed at
this portion of the molecule . This question was approached in the following
manner. Radioimmunoassay of rat anti-BP was performed by serially diluting
hyperimmune rat serum in three ways : with diluting buffer, diluting buffer
containing 100 molar excess of BP, and diluting buffer containing 100 molar
excess of EF. The results of a representative experiment with a Le anti-BP serum
are shown in Fig. 3 . Complete inhibition of binding was obtained with 100 molar
excess BP, but none was obtained with 100 molar excess EF, even at the greatest
dilution of the serum. When BN anti-BP anti sera were studied in the same
manner comparable results were obtained. These inhibition studies indicated
that EF does not react with anti-BP antibody which likely is directed at a site
other than the EF .
Discussion
In previous studies we have demonstrated in the Le rat that GPBP is a more
potent encephalitogen than either rat BP or bovine BP ; and that the encephalito-
genic potency of the 43 residue EF is identical to that of the respective intact BP
when administered on an equimolar basis (1) . In the present study, Le rats
challenged with GPBP, under the conditions routinely empolyed to produce EAE
Day32* Day 48$
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BN0.62t0.4
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r- r-II
10 20 40 80 160
DILUTION RAT ANTI-BP SERUM
FIG. 3.
￿
Titration of Le rat serum with anti-BP antibody. When diluted in 100 molar excess of
intact GPBP there was inhibition of binding; however, no inhibition was observed with 100
molar excess of EF.
in this strain, developed delayed skin tests to both GPBP and to the GPEF and
cells from their draining lymph nodes incorporated [3H]thymidine and produced
MIF when incubated in vitro with either antigen. BN rats which do not develop
EAE, developed positive delayed skin tests against GPBP, but the magnitude of
the response was considerably less than that seen in Le rats. The results of in
vitro tests with GPBP were consistent with these observations. No skin response
was seen in BN rats to the EF, however, and cells from draining nodes did not
incorporate [3H]thymidine or produce MIFwhen incubated with this fragment in
vitro. The cell-mediated immune response to GPBP which BN rats developed
appears, therefore, to be against a portion ofthe molecule other than the EF.
In Le rats, the demonstration of a delayed skin test and the capacity to develop
in vitro evidence of cell-mediated immunity tothe EF are consistent with a T-cell
response against this determinant. These findings, coupled with data dem-
onstrating genetic control of the capacity to develop EAE in rats (2, 3), sup-
port the concept that the so called Ir-EAE gene functions by regulation of the
T-cell response against the EF portion of the GPBP molecule.
Both strains of rat were shown to develop antibody against GPBP by80
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radioimmunoassay. Antigen binding in this system is related to both antibody
concentration and antibody affinity (12). These properties are best reflected by
expressing the data as ABC which has been used in other antibody systems (7, 9,
13). Using this approach, it was demonstrated that Le rats developed a small but
detectable primary responseto GPBP. BNrats did not show detectable antibody
by radioimmunoassay but probably developed in minimal response as indicated
by the results of RIEP. After secondary challenge, both strains of rat showed a
rise in ABC; however, this was far greater in the Le strain of rat. The precise
determinant(s) against which antibody is directed in the rat is not known. We
elected to use an inhibition assay, (rather than the direct radioimmunoassay) to
determine whether antibody was directed at the EF portion ofthe molecule since
iodination ofthe single tryosine ofEF (Fig. 1) might alter its capacity to bind in
this system. The inhibition studies indicate that the antibody in both strains of
rat is directed at some determinant(s) other than the EF. Thus, as has been
demonstrated with glucagon in the mouse (14), the T cells of the Le rat react
primarily with one portion of the GPBP while B cells react with another portion.
Since both strains of rats produce antibody, it would appear that recognition of
the antibody determinant(s) is controlled by a gene otherthan the Ir-EAE gene.
Studies of carrier-hapten systems have shown that although T cells and B cells
recognize different determinants during the production of antibody, the T-cell
determinant functions as a helper determinant in the production of antibody
(15). It is possible to interpret our findings according to this system and to
postulate that the EF contains a helper determinant for the production of
antibody in Le rats. When viewed in this fashion, BN rats would have B cells
which respond to the antibody determinant but which produce only minimal
amounts of antibody because they lack T cells with the capacity to recognizethe
helper determinant. Boosting with antigen results in greater proliferationofthe B
cells and a detectable secondary response.
Summary
After challenge with guiena pig basic protein (GPBP) Lewis (Le) rats, which are
homozygous for the immune response experimental allergic encephalomyelitis
(Ir-EAE) gene, developed positive delayed skin tests against GPBP and the 43
residue encephalitogenic fragment (EF); in addition, Le rat lymph node cells
(LNC) were stimulated and produced migration inhibitory factor (MIF) when
incubated in vitro with these antigens. In contrast Brown Norway (BN) rats,
which lack the Ir-EAE gene, did not develop delayed skin tests to EF and their
LNC were not stimulated and did not produce MIF when incubated in vitro with
EF. These observations indicate that the Ir-EAE gene controls a T-cell response
against the EF.
Le rats produced measurable anti-BP antibody by radioimmunoassay after
primary challenge. Although no antibody was detectable in BN rats by
radioimmunoassay, radioimmunoelectrophoresis indicated that a small amount
of antibody was formed after primary immunization. After boosting intraperito-
neally, both strains ofrat exhibited a rise in anti-BP antibody; whichwas greaterMCFARLIN, HSU, SLEMENDA, CHOU, AND KIBLER
￿
81
in Le rats. In both strains of rat the anti-BP antibody reacted with a portion of
the molecule other than the EF. Since EF primarily evokes a T cell response, it is
suggested that the EF portion of the BP molecule may contain a helper
determinant in antibody production.
Received for publication 3 September 1974.
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